All In MedTech

Device Trial Radar · NCT06749496

Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of Wear

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 134 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

134

Actual

Start

Jan 7, 2025

Primary completion

Mar 20, 2025

Study completion Mar 20, 2025

Sponsor

Lead sponsor
Johnson & Johnson Vision Care, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Dec 27, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 39 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a prospective, multi-site, 4-visit, bilateral, dispensing, randomized, controlled, double-masked, 2x2 crossover study to evaluate subjective comfort, overall opinion and end of day comfort following wear of two different contact lenses.

Conditions

  • Astigmatism

Interventions

  • Test LensDevice

    ACUVUE® OASYS MAX 1-Day for ASTIGMATISM (AOM1DfA).

  • Control LensDevice

    Alcon DAILIES TOTAL1® for Astigmatism Contact Lenses (DT1fA).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Long Lasting ComfortTime frame: 1-week Follow-up

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Stam & Associates Eye Care

    Jacksonville, Florida

11 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.